Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (14438)	5/8/2002 11:22:19 AM
From: Paul Senior	Read Replies (1) \| Respond to of 78515

Buying KNDL today. Something's not right with this one. Dropping quickly to new lows yesterday and again today. And on such a strong up day for stocks? Latest earnings report doesn't look that bad to me. Kendle "provides a broad range... of drug and development services" to pharma. and biotech companies, and outsourcing still seems the way for these companies. If KNDL can just get and keep its share of that outsourced business... As far as I can tell, Marty Whitman still has a chunk of KNDL. It may be "safe and cheap" to him, but it doesn't seem that way this morning. Looks unsafe and cheap to me -g-. But attractive enough (sells below stated book value and under 1x revenues) that I'll buy. Paul Senior